| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/29/2004 | WO2004062665A1 Heteroaryl- substituted pyrrolo` 2, 3- b! pyridine derivatives as crf receptor antagonists |
| 07/29/2004 | WO2004050123A3 Concentrated liquid valdecoxib composition |
| 07/29/2004 | WO2004050111A3 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 07/29/2004 | WO2004047866A3 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004041304A3 Pain relief agents |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003070881A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2002069883A3 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147730 Inhibitors against galectins |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147606 Medicinal compositions |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147571 Substituted oxazoles and thiazoles as hppar alpha agonists |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147531 Neurodegradation diseases; alzheimer's disease; down's syndrome; antidiabetic agents |
| 07/29/2004 | US20040147528 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; |
| 07/29/2004 | US20040147526 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147516 Blocking interleukins; antiinflammatory agents; autoimmune diseases ; antiarthritic agents; osteoporosis |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147487 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 07/29/2004 | US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147435 Compositions and methods for importing biologically active molecules into cells and for treating inflammation |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146591 Solvent extraction, mixing with aqueous solution; drying; sterilization; drugs, food; aging resistance, cognition activators , brain disorders; incontinence; Alzheimer's disease, autism, Parkinson's disease, antiarthritic agents |
| 07/29/2004 | US20040146587 Mixture containing aloe vera , plant extracts and water; amalgesics for muscle and joint pain |
| 07/29/2004 | US20040146548 Enhances percutaneous absorption of anti-inflammatory agent |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | DE10303671A1 New 8alpha,14beta-dialkyl-18-nor steroids useful as pharmaceuticals, intermediates or carriers for treating e.g. tumors, alzheimers disease |
| 07/29/2004 | DE10301917A1 Use of porphyrin precursors for photodynamic therapy of psoriasis and inflammatory skin and joint diseases |
| 07/29/2004 | CA2513042A1 Blood-brain barrier disruption inhibitor |
| 07/29/2004 | CA2512336A1 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
| 07/29/2004 | CA2510516A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | CA2509202A1 Fused heterocyclic derivatives as ppar modulators |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440157A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440076A1 Silicon compounds |
| 07/28/2004 | EP1440072A2 Purine analogs having hsp90-inhibiting activity |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP1439858A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439833A1 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 07/28/2004 | EP1439830A1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 07/28/2004 | EP1322593B1 O-substituted 6-methyl-tramadol derivatives |
| 07/28/2004 | EP1322592B1 Substituted 1-aminobutan-3-ol derivatives |
| 07/28/2004 | EP1284744B1 Antimigraine combination comprising sapindus and emblica extracts |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP1073430B1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 07/28/2004 | EP1058698B1 Preparation for prevention and healing of inflammation affections |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP0931065B1 use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | EP0752884B1 Method of treating auto-immune diseases using type one interferons |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516699A Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516693A Benzimidazoles that are useful in treating sexual dysfunction |
| 07/28/2004 | CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516601A Orally deliverable pharmaceutical composition comprising drug of low water solubility (cox-2 inhibitor), solvent, fatty acid and organic amine |
| 07/28/2004 | CN1516596A Method of modulating activity of calcium channels in cardiac cells and reagents therefor |
| 07/28/2004 | CN1516594A Preventives of remedies for arthritis |